iShares Biotechnology ETF $IBB Stock Holdings Lifted by IFP Advisors Inc

IFP Advisors Inc grew its position in iShares Biotechnology ETF (NASDAQ:IBB) by 39.3% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 49,988 shares of the financial services provider’s stock after purchasing an additional 14,115 shares during the period. IFP Advisors Inc owned about 0.10% of iShares Biotechnology ETF worth $9,507,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. Darwin Wealth Management LLC acquired a new position in iShares Biotechnology ETF in the second quarter worth approximately $25,000. Basepoint Wealth LLC bought a new stake in iShares Biotechnology ETF in the fourth quarter worth approximately $26,000. Pension & Wealth Management Advisors Inc. acquired a new position in shares of iShares Biotechnology ETF during the 2nd quarter worth $28,000. Cary Street Partners Financial LLC acquired a new position in shares of iShares Biotechnology ETF during the 4th quarter worth $29,000. Finally, Copia Wealth Management acquired a new position in shares of iShares Biotechnology ETF during the 4th quarter worth $34,000. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Performance

iShares Biotechnology ETF stock opened at $205.49 on Thursday. iShares Biotechnology ETF has a 1-year low of $138.79 and a 1-year high of $217.12. The firm’s fifty day simple moving average is $199.14 and its 200-day simple moving average is $181.02.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, June 18th. Shareholders of record on Monday, June 15th were issued a dividend of $0.0238 per share. This represents a $0.10 annualized dividend and a yield of 0.0%. The ex-dividend date was Monday, June 15th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.